Long-read genome sequencing: Transforming genetic diagnostics for rare diseases

Despite rapid advances in genome and exome sequencing, many individuals with rare diseases remain undiagnosed. In a Perspective article published in Nature Genetics, researchers at Karolinska Institutet highlight how long-read whole genome sequencing, LR-WGS, offers a paradigm shift in genetic testing.

See also  Boehringer Ingelheim appoints Shashank Deshpande as Chairman of Board of Managing Directors
Total
0
Share
Need Help?